Pregnancy and contraception in young women with congenital heart disease: General considerations

Paediatrics and Child Health

Volumn 16, Issue 4, 2011, Pages

  Wald, Rachel M ^a,b   Sermer, Mathew ^b,c   Colman, Jack M ^d,e  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Congenital heart disease; Contraception; Management; Pregnancy

Indexed keywords

DESOGESTREL; ESTROGEN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; WARFARIN;

ANEMIA; ANTICOAGULANT THERAPY; AORTA DISSECTION; AUTOSOMAL DOMINANT INHERITANCE; BACTEREMIA; BLOOD VOLUME; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CESAREAN SECTION; CONGENITAL HEART DISEASE; CONTRACEPTION; CYANOSIS; DEATH; DIABETES MELLITUS; ENDOCARDITIS; FAMILY PLANNING; FEMALE; FEMALE STERILIZATION; FETUS ECHOGRAPHY; HEART ARRHYTHMIA; HEART OUTPUT; HEART RATE; HIGH RISK PREGNANCY; HUMAN; HYPERTENSION; INTRAUTERINE DEVICE EXPULSION; LOW BIRTH WEIGHT; LUNG EDEMA; MATERNAL CARE; MATERNAL MORBIDITY; MATERNAL MORTALITY; MATERNAL SMOKING; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN ASSESSMENT; NEWBORN DEATH; NEWBORN MORTALITY; OBESITY; PATIENT COUNSELING; PATIENT DECISION MAKING; PREDICTOR VARIABLE; PREGNANCY; PREMATURITY; PRENATAL CARE; PRENATAL DIAGNOSIS; RECURRENCE RISK; REVIEW; RISK ASSESSMENT; STROKE; THROMBOSIS; TREATMENT CONTRAINDICATION; VAGINAL DELIVERY; VASCULAR RESISTANCE;

EID: 80053936362     PISSN: 12057088     EISSN: None     Source Type: Journal    
DOI: 10.1093/pch/16.4.e25     Document Type: Review

References (34)

1. Wald RM, Sermer M, Colman JM. Pregnancy in young women with congenital heart disease: Lesion-specific considerations. Paediatr Child Health 2011. (In press)
2. Pirani BB, Campbell DM, MacGillivray I. Plasma volume in normal first pregnancy. J Obstet Gynaecol Br Commonw 1973;80:884-7.
3. Robson SC, Hunter S, Boys RJ, Dunlop W. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol 1989;256:H1060-5.
4. Duvekot JJ, Cheriex EC, Pieters FA, Menheere PP, Peeters LH. Early pregnancy changes in hemodynamics and volume homeostasis are consecutive adjustments triggered by a primary fall in systemic vascular tone. Am J Obstet Gynecol 1993;169:1382-92. (Pubitemid 24009165)
5. Taylor DJ, Lind T. Red cell mass during and after normal pregnancy. Br J Obstet Gynaecol 1979;86:364-70. (Pubitemid 9141437)
6. Abbas AE, Lester SJ, Connolly H. Pregnancy and the cardiovascular system. Int J Cardiol 2005;98:179-89. (Pubitemid 40431162)
7. Karamermer Y, Roos-Hesselink JW. Pregnancy and adult congenital heart disease. Expert Rev Cardiovasc Ther 2007;5:859-69. (Pubitemid 47496679)
8. Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001;104:515-21. (Pubitemid 32738118)
9. Silversides CK, Colman JM, Siu SC. Physiology and management of pregnancy in the young adult with congenital heart disease. In: Allen HD, Driscoll DJ, Shaddy RE, Feltes TF, eds. Moss and Adams' Heart Disease in Infants, Children, and Adolescents: Including the Fetus and Young Adult, 7th edn. Philadelphia: Lippincott, Williams and Wilkins, 2008:1431-41.
10. Khairy P, Ouyang DW, Fernandes SM, Lee-Parritz A, Economy KE, Landzberg MJ. Pregnancy outcomes in women with congenital heart disease. Circulation 2006;113:517-24.
11. Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Outcome of pregnancy in women with congenital heart disease: A literature review. J Am Coll Cardiol 2007;49:2303-11. (Pubitemid 46891708)
12. Siu SC, Colman JM, Sorensen S, et al. Adverse neonatal and cardiac outcomes are more common in pregnant women with cardiac disease. Circulation 2002;105:2179-84. (Pubitemid 34517162)
13. Nora JJ. From generational studies to a multilevel genetic-environmental interaction. J Am Coll Cardiol 1994;23:1468-71. (Pubitemid 24158019)
14. Uebing A, Steer PJ, Yentis SM, Gatzoulis MA. Pregnancy and congenital heart disease. BMJ 2006;332:401-6. (Pubitemid 43797384)
15. Whittemore R, Wells JA, Castellsague X. A second-generation study of 427 probands with congenital heart defects and their 837 children. J Am Coll Cardiol 1994;23:1459-67. (Pubitemid 24158018)
16. Nora JJ, Nora AH. Maternal transmission of congenital heart diseases: New recurrence risk figures and the questions of cytoplasmic inheritance and vulnerability to teratogens. Am J Cardiol 1987;59:459-63. (Pubitemid 17032903)
17. Rychik J, Ayres N, Cuneo B, et al. American Society of Echocardiography guidelines and standards for performance of the fetal echocardiogram. J Am Soc Echocardiogr 2004;17:803-10. (Pubitemid 38858033)
18. Tworetzky W, McElhinney DB, Reddy VM, Brook MM, Hanley FL, Silverman NH. Improved surgical outcome after fetal diagnosis of hypoplastic left heart syndrome. Circulation 2001;103:1269-73. (Pubitemid 32221351)
19. Franklin O, Burch M, Manning N, Sleeman K, Gould S, Archer N. Prenatal diagnosis of coarctation of the aorta improves survival and reduces morbidity. Heart 2002;87:67-9. (Pubitemid 34074958)
20. Oberhansli I, Extermann P, Jaggi E, Pfizenmaier M. Fetal echocardiography in pregnancies of women with congenital heart disease - clinical utility and limitations. Thorac Cardiovasc Surg 2000;48:323-7. (Pubitemid 32004939)
21. Yates RS. The influence of prenatal diagnosis on postnatal outcome in patients with structural congenital heart disease. Prenat Diagn 2004;24:1143-9. (Pubitemid 40053038)
22. Thangaroopan M, Wald RM, Silversides CK, et al. Incremental diagnostic yield of pediatric cardiac assessment after fetal echocardiography in the offspring of women with congenital heart disease: A prospective study. Pediatrics 2008;121:e660-5.
23. Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Developed in collaboration with the Society of Cardiovascular Anesthesiologists: Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006;114:e84-231.
24. Siu SC, Colman JM. Heart disease and pregnancy. Heart 2001;85:710-5.
25. Meijboom LJ, Vos FE, Timmermans J, Boers GH, Zwinderman AH, Mulder BJ. Pregnancy and aortic root growth in the Marfan syndrome: A prospective study. Eur Heart J 2005;26:914-20. (Pubitemid 40676572)
26. Rossiter JP, Repke JT, Morales AJ, Murphy EA, Pyeritz RE. A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am J Obstet Gynecol 1995;173:1599-606.
27. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: Guidelines from the American Heart Association: A guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007;116:1736-54.
28. Fraser IS. Forty years of combined oral contraception: The evolution of a revolution. Med J Aust 2000;173:541-4.
29. Miner PD. Contraceptive choices for females with congenital heart disease. Prog Pediatr Cardiol 2004;19:15-24. (Pubitemid 38569511)
30. Thorne S, MacGregor A, Nelson-Piercy C. Risks of contraception and pregnancy in heart disease. Heart 2006;92:1520-5. (Pubitemid 44578860)
31. Canobbio MM, Perloff JK, Rapkin AJ. Gynecological health of females with congenital heart disease. Int J Cardiol 2005;98:379-87. (Pubitemid 40247925)
32. Bosentan: New preparation. Pulmonary hypertension: An option before epoprostenol infusion. Prescrire Int 2005;14:47-50.
33. Korver T, Klipping C, Heger-Mahn D, Duijkers I, van Osta G, Dieben T. Maintenance of ovulation inhibition with the 75-microg desogestrel-only contraceptive pill (Cerazette) after scheduled 12-h delays in tablet intake. Contraception 2005;71:8-13. (Pubitemid 41583141)
34. Lopes P, Gibon E, Linet T, Philippe HJ. Hysteroscopic tubal sterilization with Essure intratubal devices: A case-control prospective with inert local anesthesia or without anesthesia. Eur J Obstet Gynecol Reprod Biol 2008;138:199-203. (Pubitemid 351726041)